Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | LARA LARA, C. |
| Género | - |
| Área Principal WOS | Cardiac & Cardiovascular Systems; Peripheral Vascular Disease; Clinical Neurology; |
| Afiliación Principal | Hospital Hernán Henríquez Aravena |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Cardiac & Cardiovascular Systems | 5 |
| Peripheral Vascular Disease | 3 |
| Clinical Neurology | 2 |
| Medicine, General & Internal | 1 |
| Gastroenterology & Hepatology | 1 |
| Hematology | 1 |
| Scopus | #Pub |
|---|---|
| Cardiology And Cardiovascular Medicine | 2 |
| SciELO | #Pub |
|---|
| Institución | # Pub |
|---|---|
| Hospital Hernán Henríquez Aravena | 8 |
| Centro Médico Stockins Y Larenas | 1 |
| Palabra Clave | #Pub |
|---|---|
| stroke | 5 |
| atrial fibrillation | 4 |
| warfarin | 3 |
| prevention | 3 |
| oral anticoagulants | 3 |
| mortality | 3 |
| metaanalysis | 3 |
| edoxaban | 3 |
| management | 2 |
| therapy | 2 |
| etiology | 2 |
| dabigatran | 2 |
| anticoagulation | 2 |
| bleeding | 2 |
| severity | 1 |
| persistent | 1 |
| pharmacokinetics | 1 |
| population | 1 |
| predicting stroke | 1 |
| quality of life | 1 |
| quality-of-life | 1 |
| risk factors | 1 |
| risk-factor | 1 |
| rivaroxaban | 1 |
| safety | 1 |
| pancreatitis | 1 |
| south-america | 1 |
| anticoagulants | 1 |
| stroke prevention | 1 |
| survival | 1 |
| systolic heart-failure | 1 |
| anticoagulant | 1 |
| thromboembolism | 1 |
| update | 1 |
| utility | 1 |
| american-college | 1 |
| generation | 1 |
| cerebral hemorrhage | 1 |
| clinical trial | 1 |
| cohort | 1 |
| collaboration | 1 |
| cost-effectiveness | 1 |
| death | 1 |
| bioprosthetic valve | 1 |
| epidemiology | 1 |
| atlanta classification | 1 |
| factor xa inhibitor | 1 |
| case-fatality | 1 |
| guidelines | 1 |
| hemorrhage | 1 |
| inhibition | 1 |
| intensity | 1 |
| alcohol | 1 |
| association task-force | 1 |
| association | 1 |
| myocardial-infarction | 1 |
| apixaban | 1 |
| outcomes | 1 |